Notebook

Table of Contents Fisher Case Is Settled Loaded Questions Malaria Immunity Scientific Immigration Slips Terminating Telomerase Getting Tough With E.Coli Hospitable Merger `No Confidence' Vote For Confide Mendel's Mighty Midgets Bullish on Cloning Research 'A VICTORY': Bernard Fisher accepted a favorable settlement in a long-running dispute with the government and the University of Pittsburgh. Showered with praise, apology, and a financial settlement, cancer surgeon Bernard Fisher has triump

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Table of Contents Fisher Case Is Settled Loaded Questions Malaria Immunity Scientific Immigration Slips Terminating Telomerase Getting Tough With E.Coli Hospitable Merger `No Confidence' Vote For Confide Mendel's Mighty Midgets Bullish on Cloning Research 'A VICTORY': Bernard Fisher accepted a favorable settlement in a long-running dispute with the government and the University of Pittsburgh. Showered with praise, apology, and a financial settlement, cancer surgeon Bernard Fisher has triumphed in a three-year struggle to defend his reputation. In 1994, the University of Pittsburgh acceded to demands by the National Cancer Institute (NCI) to remove Fisher after 27 years as chairman and principal investigator of the federally funded National Surgical Adjuvant Breast and Bowel Project (NSABP). Earlier, Fisher had told NCI that an NSABP investigator in Canada had falsified records of women in a study. The Office of Research Integrity later filed charges of scientific misconduct against Fisher. He responded by initiating ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies